Bank of America’s Repros Therapeutics Inc. RPRX Stock Holding History

Bank of America’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-600	Closed	-$6K	–	8228
2014 Q4	$6K	Sell	600 -3,000	-83%	-$25.6K	﹤0.01%	7263
2014 Q3	$36K	Buy	3,600 +2,700	+300%	+$40K	﹤0.01%	6745
2014 Q2	$16K	Sell	900 -1,900	-68%	-$31K	﹤0.01%	7280
2014 Q1	$50K	Sell	2,800 -17,700	-86%	-$343K	﹤0.01%	6422
2013 Q4	$376K	Sell	20,500 -69,500	-77%	-$1.31M	﹤0.01%	5022
2013 Q3	$2.41M	Sell	90,000 -79,700	-47%	-$1.71M	﹤0.01%	3082
2013 Q2	$3.13M	Buy	+169,700	New	+$3M	﹤0.01%	2726

Bank of America's RPRX Position: Q1 2018 in Review

Bank of America sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 24,992 shares — an estimated $16K sold.

Bank of America first reported a position in RPRX in Q2 2013 and held it in 19 quarters. The position peaked at $4.13M in Q2 2014. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

Bank of America reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
Bank of America sold 24,992 Repros Therapeutics Inc. shares in Q1 2018, an estimated $16K.
Bank of America first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 19 quarters.
Bank of America's Repros Therapeutics Inc. position peaked at $4.13M in Q2 2014.
1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on Bank of America's 13F filing for Q1 2018, filed 15 May 2018.